Sidra Medicine, is developing a new Sensory Integration Gym as part of its continued expansion of specialized pediatric rehabilitation services. The gym will provide an advanced therapeutic environment for children with neurodevelopmental, behavioral, and sensory processing challenges.
Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of hospitals in the world, to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-based gene therapy treatment.
Sidra Medicine, has successfully performed a sacral neuromodulation implantation procedure on an eight-year-old child with spina bfida.
To mark World Health Day on April 7, Sidra Medicine reinforces its role as a research-driven, patient-centered healthcare organization by announcing its latest service launches and expansion plans for 2026.
Sidra Medicine, a member of Qatar Foundation, has provided specialized treatment to a child from Egypt diagnosed with Duchenne Muscular Dystrophy (DMD).
Sidra Medicine, Qatar’s specialist women’s and children’s hospital and a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six year old patient with a rare genetic condition.
Sidra Medicine and QatarEnergy have signed a Memorandum of Understanding (MoU) to set a framework for mutual collaboration across healthcare services, professional development opportunities, and the exchange of expertise.
Sidra Medicine, a member of Qatar Foundation, has reached a significant milestone in its digital transformation journey, with formal validation of achieving Stage 6 in both HIMSS EMRAM and HIMSS DIAM.
The MoU is aimed at strengthening collaboration in healthcare innovation, supporting the development of emerging medical technologies, and expanding partnership opportunities between medical research ecosystems and healthcare-focused venture investment.
